Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Quigley

Showing results (631-640 of 748) with videos related to

Pageof 75
Sort By:
The Journal of Clinical Endocrinology and Metabolism|March 1, 1994
Characterization of mutant androgen receptors causing partial androgen insensitivity syndromeA De Bellis, C A Quigley, K B Marschke, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
Effect of growth hormone (GH) treatment on bone in postpubertal GH-deficient patients: a 2-year randomized, controlled, dose-ranging studyStephen M Shalet, Elena Shavrikova, Morris Cromer, et al.
The Prostate|December 12, 2019
Prostate cancer research: The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy MeetingAndrea K Miyahira, Adam Sharp, Leigh Ellis, et al.
Molecular Endocrinology (Baltimore, Md.)|July 1, 1992
Complete androgen insensitivity due to deletion of exon C of the androgen receptor gene highlights the functional importance of the second zinc finger of the androgen receptor in vivoC A Quigley, B A Evans, J A Simental, et al.
The Journal of Clinical Endocrinology and Metabolism|May 31, 2013
GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trialWerner F Blum, Judith L Ross, Alan G Zimmermann, et al.
Investigative Ophthalmology & Visual Science|September 26, 2003
Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma modelKeith R G Martin, Harry A Quigley, Donald J Zack, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 8, 2002
Independent effects of reported sexually transmitted infections and sexual behavior on HIV-1 prevalence among adult women, men, and teenagers in rural UgandaLucy M Carpenter, Anatoli Kamali, Mary Payne, et al.
Cell Reports|July 19, 2016
Gene Expression Architecture of Mouse Dorsal and Tail Skin Reveals Functional Differences in Inflammation and CancerDavid A Quigley, Eve Kandyba, Phillips Huang, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1992
Complete deletion of the androgen receptor gene: definition of the null phenotype of the androgen insensitivity syndrome and determination of carrier statusC A Quigley, K J Friedman, A Johnson, et al.
Mechanisms of Ageing and Development|November 16, 2004
Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH(2)- and carboxyl-terminal interactionCharmian A Quigley, Jiann-an Tan, Bin He, et al.
Pageof 75

Showing results (631-640 of 748) with videos related to

Sort By:
Pageof 75
The Journal of Clinical Endocrinology and Metabolism|March 1, 1994
Characterization of mutant androgen receptors causing partial androgen insensitivity syndromeA De Bellis, C A Quigley, K B Marschke, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
Effect of growth hormone (GH) treatment on bone in postpubertal GH-deficient patients: a 2-year randomized, controlled, dose-ranging studyStephen M Shalet, Elena Shavrikova, Morris Cromer, et al.
The Prostate|December 12, 2019
Prostate cancer research: The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy MeetingAndrea K Miyahira, Adam Sharp, Leigh Ellis, et al.
Molecular Endocrinology (Baltimore, Md.)|July 1, 1992
Complete androgen insensitivity due to deletion of exon C of the androgen receptor gene highlights the functional importance of the second zinc finger of the androgen receptor in vivoC A Quigley, B A Evans, J A Simental, et al.
The Journal of Clinical Endocrinology and Metabolism|May 31, 2013
GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trialWerner F Blum, Judith L Ross, Alan G Zimmermann, et al.
Investigative Ophthalmology & Visual Science|September 26, 2003
Gene therapy with brain-derived neurotrophic factor as a protection: retinal ganglion cells in a rat glaucoma modelKeith R G Martin, Harry A Quigley, Donald J Zack, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 8, 2002
Independent effects of reported sexually transmitted infections and sexual behavior on HIV-1 prevalence among adult women, men, and teenagers in rural UgandaLucy M Carpenter, Anatoli Kamali, Mary Payne, et al.
Cell Reports|July 19, 2016
Gene Expression Architecture of Mouse Dorsal and Tail Skin Reveals Functional Differences in Inflammation and CancerDavid A Quigley, Eve Kandyba, Phillips Huang, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1992
Complete deletion of the androgen receptor gene: definition of the null phenotype of the androgen insensitivity syndrome and determination of carrier statusC A Quigley, K J Friedman, A Johnson, et al.
Mechanisms of Ageing and Development|November 16, 2004
Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH(2)- and carboxyl-terminal interactionCharmian A Quigley, Jiann-an Tan, Bin He, et al.
Pageof 75